OPKO Health, Inc. (LON:0KCS)
1.335
-0.026 (-1.88%)
Dec 16, 2025, 4:18 PM BST
OPKO Health Revenue
OPKO Health had revenue of $151.67M USD in the quarter ending September 30, 2025, a decrease of -12.65%. This brings the company's revenue in the last twelve months to $642.07M, down -9.75% year-over-year. In the year 2024, OPKO Health had annual revenue of $713.14M, down -17.41%.
Revenue (ttm)
$642.07M
Revenue Growth
-9.75%
P/S Ratio
1.62
Revenue / Employee
$214.24K
Employees
2,997
Market Cap
774.45M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 713.14M | -150.35M | -17.41% |
| Dec 31, 2023 | 863.50M | -140.70M | -14.01% |
| Dec 31, 2022 | 1.00B | -770.52M | -43.42% |
| Dec 31, 2021 | 1.77B | 339.31M | 23.64% |
| Dec 31, 2020 | 1.44B | 533.48M | 59.15% |
| Dec 31, 2019 | 901.94M | -88.33M | -8.92% |
| Dec 31, 2018 | 990.27M | 24.26M | 2.51% |
| Dec 31, 2017 | 966.01M | -151.49M | -13.56% |
| Dec 31, 2016 | 1.12B | 625.76M | 127.25% |
| Dec 31, 2015 | 491.74M | 400.61M | 439.63% |
| Dec 31, 2014 | 91.13M | -5.41M | -5.60% |
| Dec 31, 2013 | 96.53M | 49.49M | 105.19% |
| Dec 31, 2012 | 47.04M | 19.07M | 68.14% |
| Dec 31, 2011 | 27.98M | -515.00K | -1.81% |
| Dec 31, 2010 | 28.49M | 24.08M | 544.95% |
| Dec 31, 2009 | 4.42M | -5.02M | -53.20% |
| Dec 31, 2008 | 9.44M | 8.59M | 1,014.52% |
| Dec 31, 2007 | 847.00K | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| Genus | 672.80M |
| HUTCHMED (China) | 439.54M |
OPKO Health News
- 7 days ago - Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now - Nasdaq
- 25 days ago - Friday 11/21 Insider Buying Report: GLOO, OPK - Nasdaq
- 26 days ago - JP Morgan Initiates Coverage on OPKO Health with Neutral Rating | OPK Stock News - GuruFocus
- 26 days ago - OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - OPKO Health Inc (OPK) Q3 2025 Earnings Call Highlights: Strategic Moves and Financial Performance - GuruFocus
- 6 weeks ago - Q3 2025 OPKO Health Inc Earnings Call Transcript - GuruFocus
- 6 weeks ago - OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands - Nasdaq
- 6 weeks ago - OPK: Barrington Research Maintains Outperform Rating with $2.25 Price Target | OPK Stock News - GuruFocus